OM
Opaleye Management Portfolio holdings
AUM
$494M
1-Year Return
68.17%
This Quarter Return
+39.37%
1 Year Return
+68.17%
3 Year Return
+608.37%
5 Year Return
+807.76%
10 Year Return
+24,567.28%
AUM
$191M
AUM Growth
+$41.4M
(+28%)
Cap. Flow
-$2.25M
Cap. Flow
% of AUM
-1.18%
Top 10 Holdings %
Top 10 Hldgs %
52.91%
Holding
54
New
5
Increased
14
Reduced
20
Closed
9
Top Buys
| 1 |
BPMC
Blueprint Medicines
BPMC
|
$15.9M |
| 2 |
Prothena Corp
PRTA
|
$3M |
| 3 |
LOXO
Loxo Oncology, Inc
LOXO
|
$2.88M |
| 4 |
Agios Pharmaceuticals
AGIO
|
$2.38M |
| 5 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
$1.4M |
Top Sells
| 1 |
AMRN
Amarin Corp
AMRN
|
$3.38M |
| 2 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
$2.81M |
| 3 |
Indaptus Therapeutics
INDP
|
$2.8M |
| 4 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
$2.58M |
| 5 |
Supernus Pharmaceuticals
SUPN
|
$2.55M |
Sector Composition
| 1 | Healthcare | 86.83% |